TRADING UPDATES: Staffline and Creo Medical report higher earnings
20th Jan 2026 15:51
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Schroders Capital Global Innovation Trust PLC - London-based investment trust - Reports a net asset value of 21.42 pence per share at September 30, flat with the prior quarter. Says performance in the quarter benefitted from an upwards revaluation of Revolut Group Holdings Ltd, but with this offset by negative revaluations in companies such as Bizongo (Smartpaddle Technology Pvt Ltd), Ada Health GmbH and AgroStar (Ulink Agritech Private Ltd). Notes shareholders voted for the discontinuation of the vehicle back in February, with the trust in the process of a managed wind-down. NAV at September 30 stood at GBP136.1 million, down from GBP173.2 million at June 30. The trust said this was primarily owed to a GBP37 million initial capital return in the manner of a tender offer to shareholders. Read More
(Alliance News) - Schroders Capital Global Innovation Trust PLC on Monday said portfolio company Securiti AI has inked a definitive agreement to be acquired by Veeam Software for USD1.73 billion. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
Schroders Capital Global Innovation Trust PLC - investment trust in managed wind-down - A total of 542.2 million shares, 67.1% of total shares in issue, are tendered by shareholders in oversubscribed tender offer. Company will buy back 173.2 million of these at 21.12 pence per share, which is equal to its net asset value on May 31, less the costs of the tender. The final tender price is unchanged from the indicative price. The tender is worth GBP36.6 million. Read More
(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday. Read More
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
(Alliance News) - Schroders Capital Global Innovation Trust PLC shares jumped on Monday as it said its investee Araris Biotech AG is set to be bought for USD400 million. Read More
Schroders Capital Global Innovation Trust PLC - London-based investment trust focused on a portfolio of "highly innovative" companies - Notes second follow-on investment in iOnctura BV, a clinical-stage biotech firm that focuses on combating neglected and hard-to-treat cancers by developing experimental oral small molecule treatments designed to maximise anti-tumour efficacy while prioritising patient safety. Company invests GBP1.4 million in a funding round that raised GBP68 million. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and Wednesday, and not separately reported by Alliance News: Read More
(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Schroders Capital Global Innovation Trust PLC - London-based investment trust focused on a portfolio of "highly innovative" companies - Receives a USD5.6 million payment from Basel, Switzerland-based pharmaceutical firm, Roche Holding AG, in relation to the sale of its portfolio company Carmot Therapeutics Inc. Carmot is a Berkley, California-based biotechnology company currently focused on developing treatments for obesity and diabetes. In December, Carmot entered into an agreement to be acquired by Roche for a USD2.7 billion purchase price, alongside up to USD400 million in milestone payments. Schroders says that the USD5.6 million distribution represents a 221% fair value uplift relative to the value of its holding in Carmot of GBP1.4 million in September. Read More
(Alliance News) - Schroders Capital Global Innovation Trust PLC on Friday said it had made an investment of USD1.6 million in California-based clinical-stage cell therapy company Neurona Therapeutics. Read More
Schroders Capital Global Innovation Trust PLC - London-based investment trust with a diversified portfolio of global private and public equity companies - Receives USD5.8 million distribution related to the first milestone of the Kymab sale to Sanofi SA. In April 2021, Schroders Capital Global Innovation completed the sale of its shares in Kymab to Sanofi for initial proceeds of USD87 million. Company says: "At that time, the company explained there was the potential for additional contingent payments of up to USD27 million subject to the achievement of various development and regulatory milestones. This announced payment reflects the first milestone event, with the potential for USD21 million of further contingent payments in the future." Read More
(Alliance News) - Schroders Capital Global Innovation Trust PLC on Friday noted that its portfolio company Carmot Therapeutics Inc has been acquired by Roche Holding AG. Read More